Health Catalyst Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Health Catalyst Inc 's ROA in the second quarter of 2026?
Health Catalyst Inc recorded a cumulative net loss of $-1 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -0.25%.

However, within the Technology sector 315 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 2576, from total ROA ranking in the first quarter of 2026 at 2950.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	-40.77 %	-51.84 %	-40.72 %	-27.61 %	-7.83 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-1	-1	-1	-1	0
Return On Assets (TTM)	-0.25 %	-0.17 %	-0.11 %	-0.13 %	-0.06 %
HCAT's Total Ranking	# 2576	# 2950	# 2586	# 2560	# 2583
Total Assets (TTM) in million	359	412	503	582	605
Seq. Total Assets Change	-13 %	-17.99 %	-13.65 %	-3.85 %	-29.27 %
Seq. Net Income Change	-	-	-	-	-

HCAT's 5 Years Annual ROA >> Back to HCAT Management Effectiveness >> Compare HCAT ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 22
Sector	# 316
Overall	# 2566

Return On Assets Statistics
High	Average	Low
1.38 %	-0.05 %	-3.74 %
(Mar 31 2022)		(Jun 30 2020)

Financial Statements
Health Catalyst Inc 's Assets	$ 359 million	HCAT's Balance sheet
Health Catalyst Inc 's Income	$ 0 million	Quarterly HCAT's Income Statement
HCAT's Income by Division		See HCAT's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-40.72 %	22.85 %	-6.6 %	-9.17 %	46.2 %
Total Assets in million	503	848	690	739	813
Y / Y Net Income Change	-	-	-	-37.95 %	477.72 %
Net Income in million	-1	0	0	4	7
Annual Return On Assets	-0.14 %	-0.04 %	-0.05 %	0.58 %	0.85 %

HCAT's 5 Years Annual ROA >> Back to HCAT Management Effectiveness >> Compare HCAT ROA to its Competitors

More Return On Assets Ratios
HCAT's' Return on Assets at Yahoo Finance
Internet Services & Social Media Industry Return On Assets Trends and Statistics
Technology Sector Roa Statistics
Roa Trends for overall market
HCAT's Roa Ratio versus Internet Services & Social Media Industry, Technology Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for HCAT's Competitors
Subscribers only: Roa for Health Catalyst Inc 's Suppliers
Subscribers only: Return On Assets for HCAT's Customers

You may also want to know
HCAT's Roi	HCAT's Inventory Turnover Ratio	HCAT's Growth Rates	HCAT's Dividend Comparisons
	HCAT's Profitability Ratios	HCAT's Asset Turnover Ratio	HCAT's Dividend Growth
HCAT's Roe	HCAT's Valuation Ratios	HCAT's Financial Strength Ratios	HCAT's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Technology Sector

ROA

Date modified: 2026-09-08T18:02:50+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.